CIBC Asset Management’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Buy |
17,307
+921
| +6% | +$110K | 0.01% | 564 |
|
|
2025
Q1 | $1.8M | Sell |
16,386
-2,723
| -14% | -$300K | 0.01% | 588 |
|
|
2024
Q4 | $1.84M | Buy |
19,109
+20
| +0.1% | +$1.93K | 0.01% | 593 |
|
|
2024
Q3 | $2.18M | Sell |
19,089
-5,194
| -21% | -$593K | 0.01% | 569 |
|
|
2024
Q2 | $2.59M | Buy |
+24,283
| New | +$2.59M | 0.01% | 500 |
|
|
2022
Q2 | – | Sell |
-5,711
| Closed | -$501K | – | 1411 |
|
|
2022
Q1 | $501K | Buy |
+5,711
| New | +$501K | ﹤0.01% | 837 |
|
|
2021
Q2 | – | Sell |
-2,906
| Closed | -$249K | – | 1383 |
|
|
2021
Q1 | $249K | Sell |
2,906
-26,687
| -90% | -$2.29M | ﹤0.01% | 1076 |
|
|
2020
Q4 | $2.79M | Buy |
29,593
+3,885
| +15% | +$367K | 0.01% | 410 |
|
|
2020
Q3 | $2.24M | Sell |
25,708
-1,995
| -7% | -$174K | 0.01% | 419 |
|
|
2020
Q2 | $2.42M | Sell |
27,703
-15,215
| -35% | -$1.33M | 0.01% | 371 |
|
|
2020
Q1 | $3.54M | Sell |
42,918
-260
| -0.6% | -$21.4K | 0.03% | 279 |
|
|
2019
Q4 | $4.09M | Sell |
43,178
-244
| -0.6% | -$23.1K | 0.02% | 290 |
|
|
2019
Q3 | $3.77M | Sell |
43,422
-4,806
| -10% | -$418K | 0.02% | 298 |
|
|
2019
Q2 | $4.4M | Sell |
48,228
-28,382
| -37% | -$2.59M | 0.03% | 267 |
|
|
2019
Q1 | $6.6M | Buy |
76,610
+15,233
| +25% | +$1.31M | 0.04% | 193 |
|
|
2018
Q4 | $4.72M | Sell |
61,377
-468
| -0.8% | -$36K | 0.03% | 202 |
|
|
2018
Q3 | $4.78M | Sell |
61,845
-1,585
| -2% | -$122K | 0.03% | 230 |
|
|
2018
Q2 | $4.29M | Sell |
63,430
-2,042
| -3% | -$138K | 0.03% | 245 |
|
|
2018
Q1 | $4.74M | Sell |
65,472
-1,250
| -2% | -$90.6K | 0.03% | 226 |
|
|
2017
Q4 | $5.02M | Buy |
66,722
+348
| +0.5% | +$26.2K | 0.03% | 221 |
|
|
2017
Q3 | $5.11M | Buy |
+66,374
| New | +$5.11M | 0.03% | 216 |
|